- Report
- July 2023
- 108 Pages
North America
From €1430EUR$1,500USD£1,222GBP
- Report
- July 2023
- 121 Pages
Middle East, Africa
From €1430EUR$1,500USD£1,222GBP
- Report
- September 2021
- 354 Pages
Global
From €3809EUR$3,995USD£3,254GBP
- Report
- April 2024
- 75 Pages
Global
From €5244EUR$5,500USD£4,480GBP
- Report
- November 2020
- 96 Pages
Global
From €906EUR$950USD£774GBP
- Report
- January 2024
- 150 Pages
Global
From €4624EUR$4,850USD£3,951GBP
- Report
- November 2020
- 78 Pages
From €2002EUR$2,100USD£1,711GBP
€2860EUR$3,000USD£2,444GBP
- Report
- November 2020
- 75 Pages
Middle East, Africa
From €2002EUR$2,100USD£1,711GBP
€2860EUR$3,000USD£2,444GBP
- Report
- September 2020
- 123 Pages
Europe
From €2002EUR$2,100USD£1,711GBP
€2860EUR$3,000USD£2,444GBP
- Report
- September 2020
- 115 Pages
Asia Pacific
From €2002EUR$2,100USD£1,711GBP
€2860EUR$3,000USD£2,444GBP
- Report
- September 2020
- 95 Pages
North America
From €2002EUR$2,100USD£1,711GBP
€2860EUR$3,000USD£2,444GBP
- Report
- July 2020
- 149 Pages
Global
From €3037EUR$3,185USD£2,594GBP
€4338EUR$4,550USD£3,706GBP
- Report
- June 2020
- 114 Pages
Global
From €4529EUR$4,750USD£3,869GBP
From €2002EUR$2,100USD£1,711GBP
€2860EUR$3,000USD£2,444GBP
- Report
- May 2021
North America
From €2002EUR$2,100USD£1,711GBP
€2860EUR$3,000USD£2,444GBP
- Report
- May 2021
Asia Pacific
From €2002EUR$2,100USD£1,711GBP
€2860EUR$3,000USD£2,444GBP
- Report
- May 2021
Middle East, Africa
From €2002EUR$2,100USD£1,711GBP
€2860EUR$3,000USD£2,444GBP
From €2002EUR$2,100USD£1,711GBP
€2860EUR$3,000USD£2,444GBP
- Report
- December 2020
- 100 Pages
Global
From €4572EUR$4,795USD£3,906GBP
- Report
- January 2020
- 40 Pages
Saudi Arabia
From €2474EUR$2,595USD£2,114GBP
Allergic rhinitis, commonly known as hay fever, is a type of inflammation in the nose which occurs when the immune system overreacts to allergens in the air. Within the context of allergy and immunology, it is considered one of the most common conditions, affecting a substantial portion of the population. The market consists of various diagnostic and therapeutic options designed to manage and alleviate the symptoms of allergic rhinitis, which include sneezing, congestion, runny nose, and itchy eyes. Diagnostic methods range from skin prick tests to specific IgE blood tests, which help in identifying the allergens causing the symptoms.
Treatment typically involves allergen avoidance strategies, pharmacotherapy, and immunotherapy. Pharmacologic treatments include antihistamines, decongestants, nasal corticosteroids, and leukotriene receptor antagonists. Subcutaneous and sublingual immunotherapies are approaches to desensitize the body's response to specific allergens. The market is driven by research and development of new treatments, improved diagnostics, and the rising prevalence of allergic diseases.
Several companies that operate in the allergic rhinitis market include Merck & Co., Sanofi, GlaxoSmithKline, Johnson & Johnson, Novartis, AstraZeneca, and Pfizer. These entities engage in the manufacture and distribution of various medications, and some also provide immunotherapy options. These companies play a pivotal role in advancing the field of allergy and immunology through continuous Show Less Read more